NERV earnings date and last-quarter result: next report 2026-08-13, last quarter miss, P/E -0.15. Updated 2026-07-23.
Minerva Neurosciences (NERV) Research Hub
Minerva Neurosciences (NERV) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.2 USD (-4.35%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.15, market cap 0.03B. This hub links to the full technical, earnings and options research available for NERV.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.2 USD (-4.35%) |
| 52-week range | 2.18 USD – 5.84 USD |
| Trend regime | Range |
| 14-day RSI | 16 (Oversold) |
| Trailing P/E | -0.15 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for NERV
Covered Call on NERV: how it works, illustrative setup around the real 2.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NERV: how it works, illustrative setup around the real 2.2 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NERV: how it works, illustrative setup around the real 2.2 USD price, max profit/loss, breakeven and when to use it. Educational.
NERV technical analysis: range, last 2.2 USD, RSI 16, 52w range 2.18 USD–5.84 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NERV in?
Minerva Neurosciences (NERV) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NERV in an uptrend or downtrend?
As of 2026-10-26, NERV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NERV's trailing P/E ratio?
NERV's trailing P/E is -0.15, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does NERV next report earnings?
NERV is next scheduled to report earnings on 2026-08-13.